The global intravascular imaging market expected to reach a valuation of more than US$656.29 million by 2033, suggesting that it is positioned for substantial growth. This growth trajectory, based on industry estimations, represents a 5.4% Compound Annual Growth Rate (CAGR) and builds upon a projected market size of US$387.8 million in 2023.
With the use of intravascular imaging technology, medical personnel can precisely and sharply examine and evaluate the anatomy and disease of blood arteries, which is crucial for interventional cardiology and vascular surgery. These cutting-edge imaging techniques support cardiovascular and peripheral vascular disease diagnosis, therapy planning, and intraprocedural guidance.
Because intravascular imaging technologies enable doctors to see within blood vessels and assess their form and function, they are crucial for cardiovascular diagnosis and treatment. These imaging modalities, which include intravascular ultrasound (IVUS) and optical coherence tomography (OCT), provide high-resolution images of the coronary arteries for patients with coronary artery disease (CAD) and other vascular conditions. This allows for precise diagnosis, treatment planning, and therapeutic guidance.
Deepen Understanding With Your Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9926
In addition, the COVID-19 epidemic has brought attention to the importance of cardiovascular health and the need for creative approaches to diagnosis and treatment. As healthcare systems adapt to the challenges posed by the pandemic, intravascular imaging will become even more crucial in enhancing long-term cardiovascular outcomes, reducing procedural complications, and improving patient care.
Physician offices and other healthcare facilities are increasing demand for intravascular imaging in an attempt to reduce healthcare costs. The increasing use of intravascular imaging systems can be attributed to the demand for cost-effectiveness, flexibility, and downsizing.
It is expected that companies will keep pushing the limits of technology in the production of diagnostic equipment, which will increase the market share of intravascular imaging and drive sales of the procedure. It is anticipated that rising incidences of deep vein thrombosis, heart disease with coronary occlusion, and other ailments will increase patient traffic in diagnostic centers and fuel the intravascular imaging market’s expansion.
Key Takeaways:
- The United States is predicted to reach US$ 700 million by 2033.
- The United States is predicted to increase at a 5.6% annual rate.
- The intravascular imaging market in the United Kingdom is expected to reach US$400 million by the end of the forecast period.
- China’s intravascular imaging industry is anticipated to be worthUS$850 million.
- The intravascular imaging market in Japan is expected to develop significantly, reaching US$ 700 million by 2033.
“Due to the increased effectiveness of intravascular imaging methods for the diagnosis of blood vessel disease, broad adoption of intravascular imaging is expected to significantly increase the popularity of intravascular imaging while accelerating intravascular imaging revenue growth,” says an FMI analyst.
Get Familiar With Our Methodology:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-9926
Competitive Landscape:
In order to boost their chances of making sales abroad, the top companies in the intravascular imaging market are working to expand the reach of their products. Interregional and international market companies working together, merging and acquiring, and forming partnerships are also anticipated to encourage the growth of the intravascular imaging market share.
Some of the top key players in the intravascular imaging market include Acqiris, NIDEK CO. LTD., AGFA Healthcare, Aculight Carl Zeiss AG, Heidelberg Engineering Inc., Optopol, Sonostar Technologies Co.Ltd., OPKO Health, AlazarTech and others.
- Siemens Healthineers implemented Luminos Impulse in September 2021, a fluoroscopy technology with an innovative layout and features shared by high-end fluoroscopy systems such as a seamless imaging chain, complete dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.
- Siemens Healthineers unveiled Somatom X.ceed in May 2021, a unique high-resolution, rapid speeds CT (computed tomography) scanner designed specifically for extremely demanding clinical applications where time and precision are critical.
- Avinger Inc. announced the entire business launch of their TigereyeTM image-guided chronic total occlusion (CTO) crossing system in January 2021.
Segmentation Analysis of the intravascular imaging Market
By Product Type:
- Instruments
- Software
By Modality:
- Handheld
- Trolley Mounted
By End User:
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Long Term Care Centers
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa
In-Depth Market Overview: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/9926
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
